Connection

Perry Halushka to Nitric Oxide

This is a "connection" page, showing publications Perry Halushka has written about Nitric Oxide.
Connection Strength

0.140
  1. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. J Immunol. 2000 Feb 01; 164(3):1498-504.
    View in: PubMed
    Score: 0.036
  2. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1998 Apr 28; 95(9):4888-93.
    View in: PubMed
    Score: 0.032
  3. Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock. 1995 Feb; 3(2):102-8.
    View in: PubMed
    Score: 0.025
  4. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Am J Med Sci. 2011 Feb; 341(2):101-5.
    View in: PubMed
    Score: 0.019
  5. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. Shock. 2003 Jul; 20(1):56-62.
    View in: PubMed
    Score: 0.011
  6. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. J Leukoc Biol. 2001 Apr; 69(4):631-8.
    View in: PubMed
    Score: 0.010
  7. Reorientation of macrophage mediator production in endotoxin tolerance. Prog Clin Biol Res. 1995; 392:529-37.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.